文献速递毛发、甲与色素性疾病

白癜风临床异质性:基于临床标志物的患者聚类识别

Clinical heterogeneity in vitiligo: Identification of clinical markers based patient clusters.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2025-06-09

这项回顾性单中心研究纳入399例白癜风患者,采用层次聚类分析,无预设假设地识别出五个临床表型集群,其中两个分别定义为高活动性和广泛性患者。研究提示白癜风可根据人口学和临床特征分为不同表型。

要点

  • 白癜风患者可聚类为五个临床表型。
  • 高活动性集群疾病活动征象频率升高。
  • 广泛性集群年龄较大且受累面积最大。

核心结论

  • 白癜风患者可分为五种表型,其中两种分别定义高活动性和广泛性患者。

研究设计与样本

  • 回顾性、非干预性、单中心研究,纳入399例白癜风患者,记录人口学和临床特征后进行层次聚类分析。

主要发现

  • 聚类分析将患者分为五个集群:高活动性患者疾病活动征象频率升高并接受联合局部和系统治疗;轻度患者较年轻、受累面积小且无疾病活动征象;广泛性患者年龄较大且受累面积最大;另外两个集群为轻度或中重度疾病,皮损位于慢性皮肤摩擦部位(2A型Koebner现象)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitiligo (non-segmental) is a chronic autoimmune skin disease leading to white patches. Although vitiligo has been delineated previously, the endophenotypes of the disease are still to be defined. OBJECTIVES: The aim of this study was to investigate, without prior hypotheses, whether different clinical phenotypes of vitiligo could be identified and differ based on their demographic and clinical characteristics. METHODS: This retrospective, non-interventional, single-centre study included patients with vitiligo. Demographic and clinical characteristics of vitiligo were recorded. Hierarchical cluster analysis was then performed. RESULTS: A total of 399 patients were included. The cluster analysis classified the patients into five clusters as follows: (1) 'highly active patients' with elevated frequency of disease activity signs, receiving combinatorial topical and systemic therapy; (2) mild vitiligo patients with younger patients, low surface area involved and absence of signs of disease activity; (3) extensive vitiligo patients, with older patients and the largest surface area involved; (4) and (5) mild or moderate to severe disease, with localization of the lesions on site of chronic skin friction (type 2A koebner phenomenon). CONCLUSIONS: Patients with vitiligo can be classified into five phenotypes, with two defining the highly active and extensive patients.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Galissi L, Benoît T, Merhi R, et al. Clinical heterogeneity in vitiligo: Identification of clinical markers based patient clusters. J Eur Acad Dermatol Venereol. 2025. PMID: 40485245. doi:10.1111/jdv.20785

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。